![]() |
市场调查报告书
商品编码
1797905
全球阿育吠陀草药萃取物市场:预测至 2032 年—按类型、形式、分销管道、应用和地区进行分析Ayurvedic Herbal Extract Market Forecasts to 2032 - Global Analysis By Type, Form, Distribution Channel, Application and By Geography |
根据 Stratistics MRC 的数据,全球阿育吠陀草药萃取物市场预计在 2025 年达到 511.2 亿美元,到 2032 年将达到 831.7 亿美元,预测期内的复合年增长率为 7.2%。
阿育吠陀草药萃取物采用传统阿育吠陀技术,从药用植物浓缩物中萃取活性成分,以促进健康福祉。这些萃取物源自于拥有数百年历史的印度医学体系,由具有药用价值的草药製成。它们富含生物活性植物化学物质,有助于促进消化、免疫、减压、排毒和整体健康。此外,阿育吠陀草药萃取物也被用作膳食补充剂、机能性食品、化妆品和保健产品中人工成分的天然替代品。
据印多尔草药和阿育吠陀产品製造商协会 Ayush Nirmata Sangh 称,印多尔有大约 200 个阿育吠陀单位在运营,当地市场规模估计超过 100 亿卢比(约 1.2 亿美国)。
全球对天然植物来源产品的需求不断增长
随着全球对植物来源解决方案的需求不断增长,以及人们越来越注重健康、永续性和无化学生活方式,阿育吠陀草药萃取物在各行各业的吸引力也日益增强。这些富含生物活性化合物的萃取物被用于药物製剂、护肤品、饮料和补充剂中。全球近80%的人口的主要医疗保健来源是传统医学。此外,人们对合成化学物质长期影响的担忧日益加剧,以及对阿育吠陀等传统疗法体系的信任度日益提升,促使草药萃取物被纳入已开发市场和新兴市场的主流健康保健产品中。
缺乏国际标准和监管障碍
阿育吠陀草药萃取物市场面临一个重大障碍:缺乏广泛认可的安全和品质标准。虽然印度遵循AYUSH和GMP指南,但美国和欧盟等海外市场要求遵守更严格的FDA和EMA法规,包括安全性和有效性的科学证据。由于污染问题、活性成分含量的差异以及不同製造商使用的萃取技术不同,满足这些要求颇具挑战性。缺乏标准化法规阻碍了市场发展,尤其是在新兴经济体,草药产品被划分为补充剂、药品或食品成分,需要单独核准。
机能性食品和营养保健品的成长
阿育吠陀草药萃取物的主要成长动力之一是消费者对便利、有益健康的食品和饮料的需求。近期的趋势包括蛋白奶昔、凉茶、能量棒以及添加姜黄(姜黄素)、睡茄和余甘子等成分的即饮健康饮品。草药萃取物被引入主流食品,使其更容易被更广泛的人群所接受,包括更年轻、更注重健康的消费者。阿育吠陀萃取物供应商和快速消费品品牌可以携手合作,将这些产品定位为现代生活方式的一部分,同时保留其传统的健康益处。
来自替代自然医疗系统的竞争
传统中医 (TCM)、日本汉方医学和西方草药是一些对阿育吠陀草药萃取物构成严重威胁的传统医疗体系。这些体系拥有强大的基本客群、成熟的供应链以及在国际市场上享有盛誉的品牌。阿育吠陀萃取物很难在北美和欧洲获得认可。此外,如果没有强有力的品牌建立和教育倡议,阿育吠陀在天然保健市场中可能会被忽视。
新冠疫情 (COVID-19) 大流行导致全球对天然免疫力增强和预防性保健产品的需求激增,对阿育吠陀草药萃取物市场产生了显着的正面影响。消费者开始使用南非睡茄、吉洛伊、圣罗勒、姜黄和余甘子等阿育吠陀草药,因为它们具有抗病毒、抗炎和适应原特性。印度阿育吠陀部 (AYUSH) 透过指导方针和草药配方的分发积极推广传统疗法,全球对替代药物的兴趣导致对标准化草药萃取物的需求增加。在封锁期间,电子商务和直接面向消费者的管道蓬勃发展,使製造商能够在供应链中断的情况下进入新市场。疫情推动了向植物来源的预防性保健实践的转变,为该行业的长期增长奠定了基础。
预测期内,姜黄市场预计将占最大份额
预计姜黄将在预测期内占据最大的市场占有率,这得益于其作为强效抗氧化剂和天然抗炎剂的广泛应用。姜黄富含姜黄素,因其具有消炎、增强免疫力、促进关节和皮肤健康的功效,被广泛应用于药品、机能性食品、化妆品和膳食补充剂。这种香辛料在国内外市场上有着广泛的应用,包括传统医药、美食和现代保健产品,使其成为一股重要力量。此外,姜黄素的治疗功效得到越来越多的科学验证,以及消费者对植物来源洁净标示疗法的需求不断增长,使姜黄在阿育吠陀草药萃取物市场的主导地位得以巩固。
液体萃取物/酊剂部分预计在预测期内以最高复合年增长率成长
预计液体萃取物/酊剂细分市场将在预测期内实现最高成长率,这得益于消费者对易于使用且吸收迅速的草药的需求不断增长。与粉末和胶囊相比,液体萃取物具有更高的生物有效性,确保更快发挥健康功效。其多功能性吸引了传统和现代注重健康的消费者——它们可以直接饮用,也可以混合到饮料中,或加入功能性饮品。萃取技术的进步提高了萃取物的浓度、保质期和口感,进一步提升了其全球吸引力。此外,液体萃取物目前是成长最快的产品形式,这得益于其在膳食补充剂、草药和客製化健康配方中的应用日益增多。
预计亚太地区将在预测期内占据最大的市场占有率,这主要归功于印度丰富的药用植物供应和悠久的阿育吠陀历史。强劲的国内需求、完善的传统医药体係以及支持草药和自然保健的政府项目,共同造就了该地区的主导地位。印度是全球阿育吠陀产品的中心,是草药萃取物的主要生产国和出口国,其产品包括印度楝、睡茄和姜黄。中国、斯里兰卡和尼泊尔等国家草药的使用日益增多,进一步巩固了其市场地位。此外,亚太地区市场主导地位也归功于低廉的製造成本、丰富的原材料以及全球对阿育吠陀益处的日益认可。
预计北美将在预测期内实现最高的复合年增长率,这得益于消费者对阿育吠陀健康益处的认识不断提高,以及转向天然植物来源健康解决方案。对机能性食品、草药补充剂和洁净标示化妆品的需求不断增长,以及科学研究证实了圣罗勒、姜黄和睡茄等阿育吠陀草药的功效,也推动了这些草药的普及。该地区电子商务渗透率高,以及本地和国际品牌优质草本产品的便利供应也推动了成长。随着阿育吠陀萃取物逐渐融入主流个人护理和营养补充品产业,预计北美也将实现最高的成长率。
According to Stratistics MRC, the Global Ayurvedic Herbal Extract Market is accounted for $51.12 billion in 2025 and is expected to reach $83.17 billion by 2032 growing at a CAGR of 7.2% during the forecast period. The Ayurvedic herbal extracts are used to extract the active ingredients that support health and well-being from concentrated forms of medicinal plants that are produced using traditional Ayurvedic techniques. These extracts, which have their roots in the centuries-old Indian medical system, are made from medicinally beneficial herbs. They are rich in bioactive phytochemicals that promote digestion, immunity, stress reduction, detoxification, and general health. Moreover, the natural substitute for artificial ingredients found in dietary supplements, functional foods, cosmetics, and wellness products is the use of Ayurvedic herbal extracts.
According to the Ayush Nirmata Sangh, an association of herbal and Ayurvedic product manufacturers in Indore, highlighted that around 200 Ayurvedic units operate in Indore, with the local market estimated at over ₹1,000 crore (~US $120 million).
Growing demand for natural and plant-based products worldwide
Ayurvedic herbal extracts are becoming more and more appealing across industries as a result of the global demand for plant-based solutions being fueled by the shift toward wellness, sustainability, and chemical-free living. These extracts, which are high in bioactive compounds, are utilized in pharmaceutical formulations, skincare products, beverages, and supplements. Nearly 80% of people worldwide receive their primary healthcare from traditional medicine. Additionally, herbal extracts are increasingly being incorporated into mainstream health and wellness products in both developed and developing markets due to growing concerns about the long-term effects of synthetic chemicals and growing faith in traditional healing systems like Ayurveda.
Absence of international standards and regulatory obstacles
The market for Ayurvedic herbal extracts is severely hampered by the lack of widely recognized safety and quality standards. India follows AYUSH and GMP guidelines, but foreign markets like the US and EU demand more stringent adherence to FDA or EMA regulations, including scientific evidence of safety and efficacy. It is challenging to meet these requirements due to issues with contamination, inconsistent active ingredient levels, and different extraction techniques used by different manufacturers. Particularly in developed economies where herbal products are categorized differently-as supplements, medications, or food ingredients-and require separate approvals, this lack of standardized regulation hinders market penetration.
Growth into functional foods and nutraceuticals
One of the main growth avenues for Ayurvedic herbal extracts is consumer demand for quick, health-promoting foods and drinks. These days, protein shakes, herbal teas, energy bars, and ready-to-drink wellness drinks are being made with ingredients like turmeric (curcumin), ashwagandha, and amla. Because of their introduction into commonplace foods, herbal extracts can now be consumed by a larger range of people, including younger, health-conscious consumers. While maintaining their traditional health benefits, Ayurvedic extract suppliers and FMCG brands can work together to position these products as a part of a modern lifestyle.
Rivalry from alternative natural medicine systems
Traditional Chinese Medicine (TCM), Japanese Kampo medicine, and Western herbalism are some of the traditional medical systems that pose a serious threat to Ayurvedic herbal extracts. Strong customer bases, well-established supply chains, and well-known brands in international marketplaces are all features of these systems. It can be difficult for Ayurvedic extracts to become well-known in places like North America and Europe, where TCM products frequently take up most of the retail shelves. Furthermore, ayurveda runs the risk of becoming less prominent in the natural healthcare market if it doesn't have strong branding and education initiatives.
Due to the global surge in demand for natural immunity-boosting and preventive health products, the COVID-19 pandemic had a major positive impact on the market for Ayurvedic herbal extracts. Because of the purported antiviral, anti-inflammatory, and adaptogenic qualities of Ayurvedic herbs like ashwagandha, giloy, tulsi, turmeric, and amla, consumers began using them. Through guidelines and the distribution of herbal formulations, the Ministry of AYUSH in India actively promoted traditional remedies, and the demand for standardized herbal extracts increased due to the global interest in alternative medicine. During lockdowns, e-commerce and direct-to-consumer channels thrived, allowing manufacturers to access new markets in spite of supply chain interruptions. This shift toward plant-based, preventive wellness brought about by the pandemic has given the industry a long-term growth trajectory.
The turmeric segment is expected to be the largest during the forecast period
The turmeric segment is expected to account for the largest market share during the forecast period, driven by its widespread use as a strong antioxidant and natural anti-inflammatory. Turmeric, which is high in curcumin, is used extensively in pharmaceuticals, functional foods, cosmetics, and nutraceuticals for its ability to reduce inflammation, increase immunity, and promote joint and skin health. Due to its many applications in both domestic and international markets, including traditional medicine, cooking, and contemporary wellness products, the spice has become a major force. Moreover, turmeric's dominant position in the Ayurvedic herbal extract market is being maintained by growing scientific confirmation of curcumin's therapeutic qualities as well as rising consumer demand for plant-based and clean-label treatments.
The liquid extracts or tinctures segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the liquid extracts or tinctures segment is predicted to witness the highest growth rate, driven by growing consumer demand for herbal remedies that are simple to use and absorb quickly. Compared to powders or capsules, liquid extracts have a higher bioavailability, which guarantees a quicker onset of health benefits. Both traditional and contemporary wellness consumers find them appealing due to their versatility, which enables direct consumption, mixing with beverages, or incorporation into functional shots. Global appeal has increased due to improvements in concentration, shelf life, and taste profiles brought about by advancements in extraction technologies. Additionally, liquid extracts are now the product form with the fastest rate of growth due to their increasing use in nutraceuticals, herbal remedies, and customized wellness formulations.
During the forecast period, the Asia-Pacific region is expected to hold the largest market share, mainly due to India's extensive supply of medicinal plants and its long history of Ayurveda. Strong domestic demand, established traditional medicine systems, and government programs supporting herbal and natural healthcare all contribute to the region's advantages. As the world's center for Ayurvedic goods, India is the top producer and exporter of herbal extracts like neem, ashwagandha, and turmeric. The market position is further strengthened by the growing use of herbal remedies in nations like China, Sri Lanka, and Nepal. Furthermore, Asia-Pacific's market dominance is a result of low manufacturing costs, an abundance of raw materials, and the increasing recognition of Ayurvedic efficacy worldwide.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by growing consumer awareness of Ayurveda's health benefits and a shift toward natural, plant-based wellness solutions. Adoption is being fueled by rising demand for functional foods, herbal supplements, and clean-label cosmetics, as well as scientific research confirming the effectiveness of Ayurvedic herbs like tulsi, turmeric, and ashwagandha. Growth is also being accelerated by the region's high e-commerce penetration and the accessibility of high-quality herbal products from both domestic and international brands. Moreover, North America is the region with the fastest rate of growth due to the incorporation of Ayurvedic extracts into the mainstream personal care and nutraceutical industries.
Key players in the market
Some of the key players in Ayurvedic Herbal Extract Market include Dohler GmbH, International Flavors & Fragrances Inc, Patanjali Ayurved Limited, Aimil Pharmaceuticals Ltd, Himalaya Global Holdings Ltd, Dermapharm AG, Binexo Pharmaceuticals Inc, Kerala Ayurveda Limited, Dabur India Limited, Charak Pharma Pvt. Ltd, Kalsec Inc., Zandu (Emami Ltd.), Synthite Industries Ltd., Vicco Laboratories and The Biolandes Group.
In August 2025, International Flavors & Fragrances Inc. (IFF) has officially announced the planned sale of its soy crush, soy concentrates, and lecithin business to Bunge Global S.A., a Geneva-based global agribusiness and food company. The move was disclosed as part of IFF's second quarter financial results and reflects a broader initiative by the company to streamline operations and optimize its business portfolio.
In March 2025, Patanjali Ayurved ventures into insurance with acquisition of Magma General Insurance. The deal is subject to regulatory approvals and has been structured under a Share Purchase Agreement (SPA). Besides Sanoti Properties LLP, Celica Developers and Jaguar Advisory Services are also participating in the sale.
In July 2023, Doehler Group has acquired SVZ, a producer and supplier of liquid fruit and vegetable ingredients for the food and beverage industry. The company is known for its sustainably sourced vegetables and red berries. SVZ's portfolio features applications such as purees, juices and beverages, ice cream, dairy and alternatives, jams and fruit preparations, bakery and desserts, confectionery, soups and savory, baby food, and pet food.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.